BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8714252)

  • 1. Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics.
    Thomson KS; Prevan AM; Sanders CC
    Curr Clin Top Infect Dis; 1996; 16():151-63. PubMed ID: 8714252
    [No Abstract]   [Full Text] [Related]  

  • 2. [New beta-lactamases in enterobacteriaceae. The Danish Society of Clinical Microbiology].
    Hansen DS
    Ugeskr Laeger; 2006 Mar; 168(12):1228. PubMed ID: 16571319
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiresistant Enterobacteriaceae: new threat of an old problem.
    Pitout JD
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
    MacGowan A
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H; Gustafsson I; Ripa T
    Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamases.
    Turner PJ
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S273-5. PubMed ID: 16032564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [beta-Lactam antibiotics--mechanisms of action and resistance in Enterobacteriaceae].
    Lausová A; Bujdáková H; Kettner M
    Epidemiol Mikrobiol Imunol; 1997 May; 46(2):73-80. PubMed ID: 9264797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum beta-lactamases: how big is the problem?
    Rahal JJ
    Clin Microbiol Infect; 2000 Aug; 6 Suppl 2():2-6. PubMed ID: 11523521
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance to the latest beta-lactams: mechanisms of acquisition and spread of resistance in Enterobacteriaceae].
    Michel-Briand Y
    Bull Acad Natl Med; 2007 Jan; 191(1):35-50; discussion 50-1. PubMed ID: 17645106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases.
    Florijn A; Nijssen S; Schmitz FJ; Verhoef J; Fluit AC
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):241-3. PubMed ID: 11957033
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of beta-lactamases and the permeability barrier in resistance to beta-lactam antibiotics].
    Perduca M; Pagani L; Romero E
    Boll Ist Sieroter Milan; 1985; 64(4):281-4. PubMed ID: 3935134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute.
    Kumar MS; Lakshmi V; Rajagopalan R
    Indian J Med Microbiol; 2006 Jul; 24(3):208-11. PubMed ID: 16912442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.
    Fihman V; Lartigue MF; Jacquier H; Meunier F; Schnepf N; Raskine L; Riahi J; Sanson-le Pors MJ; Berçot B
    J Infect; 2008 Jun; 56(6):454-9. PubMed ID: 18440645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in
    De Angelis G; Del Giacomo P; Posteraro B; Sanguinetti M; Tumbarello M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global spread of New Delhi metallo-β-lactamase 1.
    Bogaerts P; Verroken A; Jans B; Denis O; Glupczynski Y
    Lancet Infect Dis; 2010 Dec; 10(12):831-2. PubMed ID: 21109171
    [No Abstract]   [Full Text] [Related]  

  • 19. Living with ESBLs. Introduction.
    Cornaglia G; Garau J; Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():1-2. PubMed ID: 18154523
    [No Abstract]   [Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamases. An overview.
    Patterson JE
    Postgrad Med; 2001 Feb; 109(2 Suppl):32-8. PubMed ID: 19667555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.